期刊文献+

全氟辛烷磺酸钾对胎鼠肝脏信号因子STAT3蛋白表达的影响 被引量:3

Study on the Effects of PFOS-K on the Expression of STAT3 Protein in Embryo of Mice
原文传递
导出
摘要 [目的]以胎鼠肝脏细胞中的信号转导及转录激活因子3(STAT3)蛋白表达的阳性细胞率(STAT3蛋白表达量)为指标,探讨全氟辛烷磺酸钾(PFOS-K)对小鼠胚胎的肝脏发育是否有影响,进而了解其胚胎毒作用。[方法]用染毒剂量分别为3、12mg/kg(按体重计)两个浓度的PFOS-K混悬液给怀孕9d的雌鼠灌胃,4d后(即怀孕第13.5天时)采用免疫组织化学法检测胎鼠肝脏的STAT3蛋白表达量。[结果]3、12mg/kg两个剂量组的阳性细胞表达率分别为41.62%和14.77%,差异有统计学意义(P<0.01)。[结论]PFOS-K能够影响小鼠胚肝脏发育过程中的信号转导因子STAT3蛋白的表达量,对哺乳动物的模式动物胎鼠肝脏细胞具有一定的胚胎毒作用。 [ Objective ] To study the effect of perfluorooctane sulfonate( PFOS-K )on the liver development in embryo of mice and the toxicity in the embryo. [ Methods ] PFOS-K solution with concentrations of 3mg/kg and 12 mg/kg in a cumulative dose series was infused through gavage into nine-day-pregnant mice. Then, 4 days after the treatment the expression of signal transduction and activators of transcription 3 ( STAT3 ) protein in the embryo liver were measured by immunohistochemistry. [ Results ] The expression rates of SATA3 protein in mice with dose 3 mg/kg and 12 mg/kg were 41.62% and 14.77%, respectively. The results showed significant difference( P 〈 0.01 ). [ Conclusion ] The results showed that PFOS-K could affect the expression amount of STAT3 protein in the embryo liver development. It could be concluded that PFOS-K has certain damage to the liver cell in embryo of mice.
出处 《环境与职业医学》 CAS 北大核心 2010年第8期488-490,494,共4页 Journal of Environmental and Occupational Medicine
关键词 全氟辛烷磺酸钾 小鼠胚胎 肝脏 免疫组织化学 信号转导及转录激活因子3 PFOS-K embryo liver immunity histochemistry signal transduction and activators of transcription 3
  • 相关文献

参考文献23

  • 1金一和,汤先伟,曹秀娟,张颖花.全球性全氟辛烷磺酰基化合物环境污染及其生物效应[J].自然杂志,2002,24(6):344-348. 被引量:47
  • 2KISSA E. Fluorinated surfactants and repellents [ M ]. 2nd ed. NY: Marcel Dekker, 2001 : 50-70.
  • 3NUMATA T, NANAO H, MORI S, et al. Chemical analysis of wear tracks on magnetic disks by TOF-SIMS [ J ]. Tribol Int, 2003, 36: 305-309.
  • 4SEACAT A M, TI-IOMFORD P J, HANSEN K J, et al. Subchronic toxicity studies on perfluurooctane sulfonate potassium salt in cynomolgus monkeys[ J ]. Toxicol Sci, 2002, 68( 1 ): 249-264.
  • 5OLSEN GW, HANSEN K J, STEVENSON LA, et al. Human donor liver and serum concentrations of perfluorooctanesulfonate and other perfluorochemi-cals [ J ]. Environ Sci Technol, 2003, 37 ( 5 ): 888-891.
  • 6SEACAT A M, THOMFORD P J, HANCEN K J, et al. Subchronic toxicity studies on perfluorooctanesulfonate potassium salt in cynomolgus monkeys[ J ]. Toxicol Sci, 2002, 68( 1 ): 249-264.
  • 7STARKOV A A, WALLACE K B. Structural determinants of fluorochemieal-induced mitochondrial dysfunction [ J ]. Toxicol Sci, 2002, 66( 2 ): 244-252.
  • 8HU W Y, JONES P D, CELIUS T, et al. Identification of genes responsive to PFOS using gene expression profiling [ J ]. Environ Toxicol Pharmacol, 2005, 19( 1 ): 57-70.
  • 9GRASTY R C, BJORK J A, WALLACE K B, et al. Effects of prenatal perfluorooctane sulfonate( PFOS ) exposure on lung maturation in the perinatal rat[ J ]. Birth Defects Res Part B Dev Reprod Toxicol, 2005, 74( 5 ): 405-416.
  • 10LUEBKER D J, York R G, HANSEN K J, et al. Neonatal mortality from in utero exposure to perfluorooctanesulfonate ( PFOS )in Sprague- Dawley rats: Dose-response, and biochemical and pharamacokinetic parameters[J]. Toxicology, 2005, 215( 1/2 ): 149-169.

二级参考文献62

  • 1周吉盛,时彦胜,靳瞻群,汪宝珍.小鼠桑椹期胚胎库的建立[J].制冷学报,1992,14(3):37-41. 被引量:2
  • 2[1]Starkov AA, Wallace KB. Structural determinants of fluorochemicalinduced mitochondrial dysfunction. Toxicol Sci, 2002, 66(2 ): 244-252
  • 3[2]Berthiaume J, Wallace KB. Perfluorooctanoate, perflourooctanesulfonate, and N-ethyl perfluorooctanesulfonamido ethanol; peroxisome proliferation and mitochondrial biogenesis. Toxicol Lett, 2002,129(1-2):23-32
  • 4[3]Sohlenius AK, Eriksson AM, Hogstrom C, et al. Perfluorooctane sulfonic acid is a potent inducer of peroxisomal fatty acid beta-oxidation and other activities known to be affected by peroxisome proliferators in mouse liver . Pharmacol Toxicol, 1993,72(2) :90-93
  • 5[4]Case MT, York RG, Christian MS. Rat and rabbit oral developmental toxicology studies with two perfluorinated compounds. Int J Toxicol 2001, 20(2) :101-109
  • 6[5]Olsen GW, Burris JM, Mandel JH, et al. Serum perfluorooctan sulfonate and hepatic and lipid clinical chemistry tests in fluorochemica production employees. Occup Environ Med, 1999, 41(9):799-806
  • 7[6]Hansen KJ, Clemen LA, Ellefson ME, et al. Compound-specific quantitative characterization of organic fluorochemicals in biologica matrices. Environ Sci Technol, 2001, 35:766-770
  • 8[7]Giesy JP, Kannan K. Global distribution of perfluorooctane sulfonate in wildlife. Environ Sci Technol, 2001, 35:1339-1342
  • 9[8]Kannan K, Franson JC, Bowerman WW, et al. Perfluorooctane sulfonate in fish-eating water birds including bald eagles and albatrosses.Environ Sci Technol, 2001, 35: 3065-3070
  • 10[9]Kannan K, Koistinen J, Beckmen K, et al. Accumulation of perfluorooctane sulfonate in marine mammals. Environ Sci Technol, 2001, 35:1593-1598

共引文献70

同被引文献58

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部